Eli Lilly has lined up another deal in the radiopharmaceutical sector, paying $140 million to partner drugs developed by Radionetics Oncology and taking an option on buying the company outright ...

Eli Lilly has unveiled a $2.5 billion deal to acquire rights to a cancer therapy being developed by Scorpion Therapeutics in a third major transaction announced on the first day of the JP Morgan ...

The fund focuses almost exclusively on US TIPS and is uncomplicated by non-US inflation-linked debt, corporates, or securitized bonds often found in competitors’ portfolios; it earns an Above ...

But the doubt disappeared shortly after remarks on inflation by a member of the rate-setting committee. Megan Greene, who voted with the majority for a hold at the last meeting in March ...